Yuhan Yanghaeng to promote CDMO business at CPHI Milan 2026
In short
Yuhan Yanghaeng said on Oct 6 that it is taking part in CPHI Worldwide 2026, a global pharmaceutical and bio exhibition in Milan, Italy, running Oct 6–8. The company said it has set up a dedicated booth and will present its new drug pipeline along with API production and CDMO capabilities through its subsidiary Yuhan Chemical.
Read the full story 1 min read
Yuhan Yanghaeng said on Oct 6 that it is taking part in CPHI Worldwide 2026, a global pharmaceutical and bio exhibition held in Milan, Italy, from Oct 6 to Oct 8 local time. The company said it has set up a dedicated booth at the event. Chosun Ilbo reported that tens of thousands of company officials and experts gather at the exhibition, which it described as a venue for discussing industry cooperation. [ 1 , 2 , 3 ]
According to Seoul Economic Daily, Yuhan intends to use the event to expand its global contract development and manufacturing organisation (CDMO) business. The company plans to present the raw-material (API) production capacity of its subsidiary Yuhan Chemical together with its new drug research and development pipeline, and to seek new cooperation opportunities with overseas pharmaceutical and bio companies. Yuhan staff handling global business, R&D and overseas sales will hold one-on-one business meetings at the show. [ 3 ]
The company said Yuhan Chemical, which handles Yuhan's API production, is continuing to increase production capacity while building a quality management system aligned with global regulatory standards, in order to win overseas customers. Yuhan plans to raise contract manufacturing volumes from existing customers and to use CPHI to find new partners for further CDMO orders, with its new drug pipeline also positioned as an asset for global partnerships, Seoul Economic Daily reported. [ 3 ]
A Yuhan official said CPHI is “an important opportunity to show Yuhan Yanghaeng's global commercialisation capabilities and technology to overseas markets,” adding that the company would strengthen cooperation with existing partners and expand new business opportunities on the basis of its innovative drug pipeline and global-level CDMO competitiveness. [ 3 ]
Why it matters
The exhibition is a venue where pharmaceutical firms negotiate supply and contract manufacturing deals, so Yuhan's push there is aimed at adding overseas customers to its CDMO and raw-material business rather than at a domestic product launch. The documents give no contract values or named partners, so the commercial outcome is not yet known.
Key facts
- Yuhan Yanghaeng said it is participating in CPHI Worldwide 2026. [ 1 , 2 , 3 ]
- The exhibition runs from Oct 6 to Oct 8 in Milan, Italy, local time. [ 2 , 3 ]
- Yuhan Yanghaeng said it has set up a dedicated booth at the event. [ 2 , 3 ]
- The company plans to present its new drug R&D pipeline and the API production and CDMO business of its subsidiary Yuhan Chemical. [ 2 , 3 ]
- Yuhan staff in global business, R&D and overseas sales will hold one-on-one meetings with global pharmaceutical and bio companies. [ 3 ]
- Chosun Ilbo reported that tens of thousands of company officials and experts gather at the event. [ 2 ]
Confirmed by several sources
- Yuhan Yanghaeng said it is attending CPHI Worldwide 2026. [ 1 , 2 , 3 ]
- The event is held in Milan, Italy, from Oct 6 to Oct 8. [ 2 , 3 ]
- Yuhan Yanghaeng is operating a dedicated booth at the event. [ 2 , 3 ]
- The company is promoting Yuhan Chemical's API production and CDMO business at the exhibition. [ 2 , 3 ]
Still unclear
- The value, size or counterparties of any CDMO contracts to be signed at the event. The documents state only a general aim to expand orders and find new partners, with no figures or named companies.
- The body text of the Newsis report, which concerns a Supreme Court matter unrelated to the exhibition. Only the Newsis headline could be used for this event, as its article text does not address the CPHI participation.
What local media are saying
Timeline, local time
- Newsis reports that Yuhan Yanghaeng is taking part in the world pharmaceutical and bio exhibition. [ 1 ]
- Chosun Ilbo reports Yuhan Yanghaeng's participation and its plan to run a dedicated booth in Milan. [ 2 ]
- Seoul Economic Daily publishes detailed plans for the CDMO push, including Yuhan Chemical's API capacity and the company's meeting schedule. [ 3 ]